---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-032512"
form_type: "8-K"
ticker: "STAA"
cik: "0000718937"
company_name: "STAAR SURGICAL CO"
filed_at: "2024-03-18T23:59:59+00:00"
generated_at: "2026-06-04T16:11:03.865413+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# STAAR Surgical surpasses 3 million cumulative ICL sales globally

## Summary
- More than 3 million Implantable Collamer Lenses (ICLs) sold worldwide; EVO ICL accounts for ~2.5 million of that total.
- CEO Tom Frinzi cites EVO ICL as next logical step in refractive innovation with clear patient outcome differentiators.
- Milestone reflects growing adoption for myopia, astigmatism, and presbyopia correction via minimally invasive procedure.

## SEC filing metadata
- accession: 0000950170-24-032512
- form_type: 8-K
- ticker: STAA
- cik: 0000718937
- company_name: STAAR SURGICAL CO
- filed_at: 2024-03-18T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/718937/000095017024032512/0000950170-24-032512-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/718937/000095017024032512/staa-20240318.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-032512
- JSON: https://secwatch.observer/filing/0000950170-24-032512.json
- Plain text: https://secwatch.observer/filing/0000950170-24-032512.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.